Find uplifting stories about heroes, innovations, and solutions
7846 results for "cancer treatment"
Blood cancer patients in Kansas can now access a one-time therapy that could replace lifelong chemotherapy cycles. The breakthrough CAR T-cell treatment genetically modifies patients' own immune cells to fight cancer.
Doctors are catching ovarian cancer earlier and keeping it away longer with personalized treatments and genetic testing. These advances are giving patients real hope where there was once only uncertainty.
Scientists discovered how to beat triple-negative breast cancer at its own game by blocking an enzyme that helps tumors survive treatment. The approach not only damages cancer cells directly but also calls in the immune system for backup.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
A groundbreaking combination therapy is giving women with HER2-positive metastatic breast cancer significantly more time, setting a new standard for first-line treatment. The DESTINY-Breast09 trial shows the treatment works across different patient groups, offering hope to thousands.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope. Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.
A small Canadian city is funding a massive expansion that will bring lifesaving chemotherapy care closer to home for cancer patients who currently face exhausting travel for treatment. Breast cancer survivor Teri Peters knows firsthand why six new treatment chairs will change everything.
A short burst of immunotherapy before surgery has kept every patient in a UK colorectal cancer trial cancer-free for nearly three years. The breakthrough challenges decades of standard treatment and offers hope for thousands.
Scientists at Oregon Health & Science University discovered that stress nerves help pancreatic tumors grow, opening doors to potential new treatments. The breakthrough could transform how we fight one of the deadliest cancers.
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
A new radiation treatment for advanced prostate cancer is helping patients skip harsh chemotherapy while getting better results. Texas Oncology in Longview is now offering Pluvicto, which delivers radiation directly to cancer cells.
Cancer patients gained several new FDA-approved tools this week, including tests to guide treatment decisions and drug combinations for hard-to-treat cancers. These advances offer fresh hope for more personalized, effective care.
A breakthrough treatment for pancreatic cancer shows promise in doubling how long patients survive with one of the deadliest forms of cancer. This medical advance offers new hope for thousands of families facing this devastating diagnosis.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
A promising new liver cancer treatment just received FDA Fast Track designation, potentially speeding up access for patients who need it most. The designation for PLT012 marks meaningful progress in the fight against one of the deadliest cancers.
A powerful new combination therapy just gained approval to help patients fighting an aggressive form of lung cancer live longer. The treatment offers hope for thousands diagnosed with extensive-stage small cell lung cancer each year.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
Scientists discovered that a natural molecule produced during fasting dramatically improves CAR T cell therapy against cancer in mice. Human trials are already underway to test whether this affordable supplement could help patients beat cancers that normally resist treatment.
A groundbreaking immunotherapy combination helped 8 in 10 multiple myeloma patients live two years without their cancer getting worse, compared to just 5 in 10 with standard treatment. The global trial involving over 860 patients offers renewed hope for those facing this difficult blood cancer.
Showing 20 of 7846